Who invested in Invenra

4 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$8.2Mraised across 4 rounds since 2012, from 4 sources

$1.2MDebt$3.0MVenture$2.0MVenture$2.0MVenture

Latest round: Venture, $2.0MAug 2015
Biggest round: $3.0MVenture · Feb 2013
Investors: 0

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2012201320142015

$1.2MDebt$3.0MVenture$2.0MVenture$2.0MVenture

First round: Debt, $1.2M
Biggest round: $3.0M
Usual gap between rounds: 13 months

The rounds

Aug 2015
Venture$2.0M
No investor was named in the report.
From a historical funding recordSEC filing: $2.0M sold, first sale Aug 2015
Jan 2015
Venture$2.0M
No investor was named in the report.
From a historical funding recordSEC filing: $2.0M sold, first sale Jan 2015
Feb 2013
Venture$3.0M
No investor was named in the report.
Reported by sec.govSEC filing: $3.0M sold, first sale Feb 2013
Jan 2012
Debt$1.2M
No investor was named in the report.
Reported by sec.govSEC filing: $1.2M sold, first sale Jan 2012

Founders and team

From Invenra's own website and the SEC filings it signed: 1 founder, 4 on the team.

Dennis ChoCo-Founder, CEO, and Chairman

Nancy J. SandyChief Commercial Officer
Sherry Boozer-HobbsHead of Protein Sciences
William HinshawDirector
Roland GreenExecutive Officer, Directori

On the board, as filediDavid SnyderEmile NuwaysirPaul WeissRichard LesniewskiStan Rose

Also claim to have backed them

These 2 firms list Invenra as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.